🇺🇸 FDA
Pipeline program

Pioglitazone

BG06-051

Approved small_molecule completed

Quick answer

Pioglitazone for Obesity is a Approved program (small_molecule) at Takeda with 1 ClinicalTrials.gov record(s).

Program details

Company
Takeda
Indication
Obesity
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials